people
The Times Higher Education (THE) released on April 30, 2014 its annual ranking of 100 top universities whose history is under 50 years.
KAIST placed 3rd, holding the same spot from last year.
The (THE) 100 Under 50 ranking used 13 indicators across five factors to measure the performance of institutions: research, citations, teaching, international outlook, and industry income. The indicators included research volume and income, reputation, learning environment, staff-to-student ratio, scholarly papers produced, and the percentage of international staff as part of the institution’s faculty.
Phil Baty, editor of the Times ranking, compared younger and older universities as follows:
“Young universities are free to be more agile, lean, and risk-taking, giving them an advantage in a rapidly changing global marketplace. They are also free to offer innovative teaching and focus their research in niche, high-impact areas.”
KAIST and Pohang University of Science and Technology (ranked first) are the only Korean universities that made the ranking list.
For the full list, please go to:
http://www.timeshighereducation.co.uk/world-university-rankings/2014/one-hundred-under-fifty
This information was provided by the Times Higher Education 100 Under 50.
-
research Researchers finds a way to reduce the overheating of semiconductor devices
The demand to shrink the size of semiconductors coupled with the problem of the heat generated at the hot spots of the devices not being effectively dispersed has negatively affected the reliability and durability of modern devices. Existing thermal management technologies have not been up to the task. Thus, the discovery of a new way of dispersing heat by using surface waves generated on the thin metal films over the substrate is an important breakthrough. KAIST (President Kwang Hyung Lee) a
2023-06-01 -
research Synthetic sRNAs to knockdown genes in medical and industrial bacteria
Bacteria are intimately involved in our daily lives. These microorganisms have been used in human history for food such as cheese, yogurt, and wine, In more recent years, through metabolic engineering, microorganisms been used extensively as microbial cell factories to manufacture plastics, feed for livestock, dietary supplements, and drugs. However, in addition to these bacteria that are beneficial to human lives, pathogens such as Pneumonia, Salmonella, and Staphylococcus that cause various in
2023-05-10 -
research A biohybrid system to extract 20 times more bioplastic from CO2 developed by KAIST researchers
As the issues surrounding global climate change intensify, more attention and determined efforts are required to re-grasp the issue as a state of “crisis” and respond to it properly. Among the various methods of recycling CO2, the electrochemical CO2 conversion technology is a technology that can convert CO2 into useful chemical substances using electrical energy. Since it is easy to operate facilities and can use the electricity from renewable sources like the solar cells or the win
2023-03-30 -
research The cause of disability in aged brain meningeal membranes identified
Due to the increase in average age, studies on changes in the brain following general aging process without serious brain diseases have also become an issue that requires in-depth studies. Regarding aging research, as aging progresses, ‘sugar’ accumulates in the body, and the accumulated sugar becomes a causative agent for various diseases such as aging-related inflammation and vascular disease. In the end, “surplus” sugar molecules attach to various proteins in the body
2023-03-15 -
research KAIST team develops smart immune system that can pin down on malignant tumors
A joint research team led by Professor Jung Kyoon Choi of the KAIST Department of Bio and Brain Engineering and Professor Jong-Eun Park of the KAIST Graduate School of Medical Science and Engineering (GSMSE) announced the development of the key technologies to treat cancers using smart immune cells designed based on AI and big data analysis. This technology is expected to be a next-generation immunotherapy that allows precision targeting of tumor cells by having the chimeric antigen receptors (C
2023-03-09